Northern Trust’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.18M | Buy |
125,933
+92,767
| +280% | +$2.89M | ﹤0.01% | 2716 |
|
|
2026
Q1 | $826K | Buy |
33,166
+18,787
| +131% | +$340K | ﹤0.01% | 3425 |
|
|
2025
Q4 | $166K | Buy |
14,379
+2,167
| +18% | +$20.6K | ﹤0.01% | 4041 |
|
|
2025
Q3 | $106K | Sell |
12,212
-4,561
| -27% | -$38.8K | ﹤0.01% | 4120 |
|
|
2025
Q2 | $120K | Sell |
16,773
-46,619
| -74% | -$381K | ﹤0.01% | 4073 |
|
|
2025
Q1 | $412K | Sell |
63,392
-300
| -0.5% | -$4.72K | ﹤0.01% | 3651 |
|
|
2024
Q4 | $1.17M | Buy |
63,692
+1,449
| +2% | +$44.2K | ﹤0.01% | 3319 |
|
|
2024
Q3 | $2.15M | Buy |
62,243
+11,978
| +24% | +$470K | ﹤0.01% | 2957 |
|
|
2024
Q2 | $1.47M | Buy |
50,265
+1,627
| +3% | +$64.3K | ﹤0.01% | 3070 |
|
|
2024
Q1 | $2.75M | Buy |
48,638
+520
| +1% | +$23K | ﹤0.01% | 2797 |
|
|
2023
Q4 | $2.06M | Sell |
48,118
-464
| -1% | -$14.7K | ﹤0.01% | 2991 |
|
|
2023
Q3 | $1.69M | Buy |
48,582
+275
| +0.6% | +$12K | ﹤0.01% | 3031 |
|
|
2023
Q2 | $2.25M | Buy |
48,307
+2,816
| +6% | +$140K | ﹤0.01% | 2944 |
|
|
2023
Q1 | $2.1M | Sell |
45,491
-565
| -1% | -$35.9K | ﹤0.01% | 2918 |
|
|
2022
Q4 | $3.72M | Buy |
46,056
+5,379
| +13% | +$374K | ﹤0.01% | 2664 |
|
|
2022
Q3 | $2.26M | Buy |
40,677
+2,979
| +8% | +$176K | ﹤0.01% | 2955 |
|
|
2022
Q2 | $1.96M | Sell |
37,698
-1,404
| -4% | -$78.4K | ﹤0.01% | 3079 |
|
|
2022
Q1 | $3.21M | Sell |
39,102
-15,420
| -28% | -$1.47M | ﹤0.01% | 2846 |
|
|
2021
Q4 | $8.11M | Buy |
54,522
+920
| +2% | +$165K | ﹤0.01% | 2384 |
|
|
2021
Q3 | $10.1M | Sell |
53,602
-1,838
| -3% | -$349K | ﹤0.01% | 2258 |
|
|
2021
Q2 | $10.3M | Buy |
55,440
+21,008
| +61% | +$4.11M | ﹤0.01% | 2339 |
|
|
2021
Q1 | $7.84M | Buy |
34,432
+3,004
| +10% | +$713K | ﹤0.01% | 2461 |
|
|
2020
Q4 | $6.82M | Buy |
31,428
+9,347
| +42% | +$1.55M | ﹤0.01% | 2490 |
|
|
2020
Q3 | $2.22M | Buy |
22,081
+166
| +0.8% | +$15.7K | ﹤0.01% | 3015 |
|
|
2020
Q2 | $1.7M | Buy |
21,915
+9,147
| +72% | +$878K | ﹤0.01% | 3120 |
|
|
2020
Q1 | $1.3M | Buy |
12,768
+550
| +5% | +$57.8K | ﹤0.01% | 3083 |
|
|
2019
Q4 | $1.34M | Buy |
12,218
+76
| +0.6% | +$7.84K | ﹤0.01% | 3297 |
|
|
2019
Q3 | $1.1M | Buy |
12,142
+4,164
| +52% | +$420K | ﹤0.01% | 3363 |
|
|
2019
Q2 | $907K | Buy |
7,978
+491
| +7% | +$54.1K | ﹤0.01% | 3391 |
|
|
2019
Q1 | $852K | Buy |
7,487
+1,055
| +16% | +$110K | ﹤0.01% | 3411 |
|
|
2018
Q4 | $580K | Buy |
+6,432
| New | +$776K | ﹤0.01% | 3519 |
|
Other funds holding STRO
KCM
Northern Trust's STRO Position: Q2 2026 in Review
Northern Trust increased its Sutro Biopharma (STRO) stake by 280% in Q2 2026, buying an estimated $2.89M and bringing the position to 125,933 shares worth $4.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2716.
Northern Trust first reported a position in STRO in Q4 2018 and has held it in 31 quarters since. The position peaked at $10.3M in Q2 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.
- Northern Trust held 125,933 shares of Sutro Biopharma worth $4.18M as of Q2 2026.
- Northern Trust bought 92,767 Sutro Biopharma shares in Q2 2026, an estimated $2.89M.
- Sutro Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2716 holding.
- Northern Trust first reported a position in Sutro Biopharma in Q4 2018 and has held it in 31 quarters since.
- Northern Trust's Sutro Biopharma position peaked at $10.3M in Q2 2021.
- 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.